Skip to content
Live funding
↑Microbiotica €42.7M Series C round led by British Business Bank ↑Goodweek €10.7M funding round led by Adara Ventures ↑Qilimanjaro Quantum Tech €19.6M raises a Series A round ↑Ambio €5.1M Seed round led by Lifeline Ventures ↑Duvo €28.5M Series A round led by Balderton Capital ↑Salience Labs €111.4M Series B round led by Bullhound Capital ↑Wavo €10M funding round led by Eurazeo ↑Cofrai €2.6M funding round led by DFF Ventures ↑Undecimal Bio €16M Seed round led by 4BIO Capital ↑Obsero €1M Seed round led by SFC Capital ↑ParkMundo €2.3M Seed round led by Rabobank ↑Ubitium €12.5M Seed round led by Ibex Investors ↑Alchera Technologies €3.2M Seed round led by Maven Capital Partners ↑Sainaptic €1.2M funding round led by Brighteye Ventures ↑reebuild €3M Seed round led by Rise PropTech ↑Causa Prima €17.9M Seed round led by Base10 Partners ↑Affinity Labs €1.8M Pre-seed round led by Antler ↑Epyr €15M Series A round led by SlateVC ↑CarbonFarm €7M Series A round led by Colam Impact ↑CMR Surgical €358.1M funding round led by Stryker
Sesame Summit 2027
Sesamers
← Startups directory

MoleSense

Pre-seed · Epalinges, Switzerland

MoleSense is an EPFL spin-off building a non-invasive sweat-sensing wearable that tracks inflammatory proteins and hormones in high-risk pregnancies.

This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.

-
Total raised
-
Valuation
11
Employees
2025
Founded

Latest round

Grant - October 28, 2025

Grant - €160,000

Grant

October 28, 2025 · Read the story
Venture Kick

Open roles

MoleSense is not hiring through Sesamers right now.

Work here? Claim the profile and post roles.

Claim your profile
Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.